NX-1607NX-1607-101MEDI0680mCRPCadvanced solid tumors
…plasmic immune checkpoint, constraining immune cell activation. NX-1607 is a first-in-class, orally bioavailable, small-molecule inhibi…
2articles mentioning drugs
17drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: NX-1607 ×
NX-1607
This drug is selected. Its supporting articles are shown below.
Articles mentioning NX-1607
2 articles · page 1 of 1NX-1607NX-1607-enhancedCasitas B lymphoma-b
…highlighting its potential as a promising immunotherapy target. NX-1607 is the first oral small molecule inhibitor of Cbl-b and it is c…